Amgen's Full Year 2012 Revenues Increased 11 Percent to $17.3 Billion and Adjusted Earnings Per Share (EPS) Increased 22 Percent to $6.51
Amgen (NASDAQ: AMGN) today announced financial results for the fourth quarter and full year of 2012. Key results include:
For the full year, total revenues increased 11 percent to $17,265 million, with 9 percent product sales growth driven by strong performance across the portfolio. Adjusted EPS grew 22 percent to $6.51 due to 15 percent adjusted operating income growth and lower shares outstanding. PR Newswire (http://s.tt/1yRgA)
For the full year, total revenues increased 11 percent to $17,265 million, with 9 percent product sales growth driven by strong performance across the portfolio. Adjusted EPS grew 22 percent to $6.51 due to 15 percent adjusted operating income growth and lower shares outstanding. PR Newswire (http://s.tt/1yRgA)